Request Trial
shutterstock_759070498_mapics
Mapics / Shutterstock.com
22 October 2019Big PharmaAnna Chrisman, EBD Group

Event preview: BIO-Europe returns to Hamburg

Supported by regional hosts, the northern Germany biomedical cluster organisation Life Science Nord, the City of Hamburg, and the State of Schleswig-Holstein, BIO-Europe 2019 is expected to bring together 4,400 executives from more than 2,300 life sciences companies from more than 60 countries.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
The curtain closes on three major drug disputes
11 February 2026   Courts on both sides of the Atlantic recorded a flurry of settlements this week, as Astellas, GSK, and Alexion drew a line under long-running disputes with generic rivals.
Big Pharma
The clinical trial dilemma: Navigating European practice
27 November 2025   Clinical trials create a patent paradox. With EPO case law rapidly reshaping the 'expectation of success' test—most recently T136/24—the line between innovation and obviousness is blurred. Amanda Simons of J A Kemp offers drafting strategies to secure protection for your downstream innovations.
Big Pharma
Report reveals surge of AI adoption in IP but lawyers remain cautious
20 November 2025   A new report from Clarivate highlights a jump in the tech’s adoption among IP professionals over the past two years, as well as concerns over governance.


Editor's picks

Novo Nordisk takes on Hims & Hers after $49 pill ‘turnaround’
Americas
Novo Nordisk takes on Hims & Hers after $49 pill ‘turnaround’
10 February 2026

Editor's picks

Americas
Novo Nordisk takes on Hims & Hers after $49 pill ‘turnaround’
10 February 2026
Americas
The quantum advantage: IP considerations for the next generation of life sciences innovation
27 January 2026
Europe
Final call: Who are the world’s best in-house counsel?
16 January 2026
Americas
Bayer enters COVID-19 vaccine row with three suits against major drugmakers
8 January 2026
Americas
SCOTUS shuts the door on Entresto ‘after-arising technology’ review
17 December 2025
Europe
Abbott appeals ‘baffling’ decision in glucose monitoring device feud
16 December 2025

More features

UPC appeals court confirms ‘all-or-nothing’ rule for unitary patents
Reaction: Emotional Perception decision is ‘good for UK PLC’
UK ruling ‘future-proofs’ patentability for AI and computer tech
The curtain closes on three major drug disputes
Novo Nordisk takes on Hims & Hers after $49 pill ‘turnaround’
Semaglutide patent battle heats up with new blow for Novo in India
Wilson Sonsini senior counsel moves to a rival firm
AstraZeneca partners with Chinese firm ahead of next obesity race